Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic
ORTOPODCZ
2 other identifiers
observational
400
1 country
7
Brief Summary
This multicenter, prospective, non-interventional observational study (ORTOPODCZ) investigates the association between preoperative cognitive impairment and postoperative delirium (POD) in older adults undergoing elective total hip arthroplasty in the Czech Republic. Postoperative delirium is a frequent and serious neurocognitive complication in senior surgical patients and is associated with increased morbidity, mortality, prolonged hospitalization, and impaired functional and cognitive outcomes. Despite international recommendations, routine preoperative cognitive screening remains insufficiently implemented. The study evaluates the predictive value of the ALBA test, a brief cognitive screening tool, performed during the pre-anesthetic assessment. Postoperative delirium will be assessed using the validated CAM-ICU instrument for up to 72 hours after surgery. Secondary objectives include assessing the relationship between POD and frailty, polypharmacy, comorbidities, type of anesthesia, intraoperative hemodynamics, blood loss, vasoactive support, and postoperative complications. Approximately 300-400 participants aged ≥65 years will be enrolled across seven centers. No additional procedures, biological sampling, or deviations from standard clinical care are required. Data will be collected in REDCap and analyzed according to a predefined statistical analysis plan. The study aims to provide robust evidence supporting the integration of cognitive screening into routine preoperative evaluation and to describe feasibility and implementation requirements for the ALBA test in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2030
February 25, 2026
February 1, 2026
3.8 years
February 18, 2026
February 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of postoperative delirium (POD)
POD will be assessed using the CAM-ICU tool. Delirium is considered present if at least one CAM-ICU assessment is positive within the first 72 hours after surgery. The outcome will be expressed as the percentage of patients with POD.
0-72 hours after surgery
Secondary Outcomes (9)
Frailty score measured using the Clinical Frailty Scale (CFS)
Preoperative assessment
Number of comorbidities present preoperatively
Preoperative assessment
Presence of polypharmacy (>5 regular medications)
Preoperative medication list
Presence of preoperative anemia
Preoperative assessment
Type of anesthesia used (general vs. regional)
0-72 hours after surgery
- +4 more secondary outcomes
Study Arms (1)
Cohort of older adults undergoing elective total hip arthroplasty
Prospective cohort of patients aged 65 years and older undergoing elective total hip arthroplasty in standard clinical care. All participants receive routine perioperative management. No interventions are assigned as part of the study.
Eligibility Criteria
Prospective cohort of patients aged 65 years and older undergoing elective total hip arthroplasty in seven hospitals in the Czech Republic. All participants receive standard perioperative care. No interventions are assigned as part of the study; only observational data are collected.
You may qualify if:
- Age ≥ 65 years
- Elective total hip arthroplasty in general or regional anesthesia
- ASA physical status I-III
- Ability to understand and cooperate during testing; no severe sensory impairment (compensatory aids allowed)
- Expected postoperative hospitalization in ICU, PACU, or standard ward
You may not qualify if:
- Glasgow Coma Scale ≤ 14
- Limited legal capacity
- Active psychiatric disorder (e.g., psychotic disorder, bipolar disorder)
- Active oncological disease
- Chronic use of strong opioids
- Premedication with anxiolytics or antipsychotics during preanesthetic evaluation
- Acute reoperation within 3 months of primary surgery
- Refusal to participate or withdrawal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
University Hospital Brno - Bohunice
Brno, 62500, Czechia
University Hospital Olomouc - Department of Anaesthesiology, Resuscitation and Intensive Care
Olomouc, 77900, Czechia
University Hospital Ostrava - Department of Anaesthesiology, Resuscitation and Intensive Care
Ostrava, Czechia
University Hospital Královské Vinohrady
Prague, 10034, Czechia
University Hospital Motol
Prague, 15006, Czechia
Vsetín Hospital
Vsetín, Czechia
Tomas Bata Regional Hospital
Zlín, 6275, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Department of Anesthesiology, Resuscitation and Intensive Car
Study Record Dates
First Submitted
February 18, 2026
First Posted
February 25, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
March 31, 2030
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because this is a multicenter observational study conducted under strict GDPR requirements. The study does not include a data-sharing framework or governance structure that would allow external access to pseudonymized datasets. Data will be used exclusively for the purposes defined in the study protocol and handled according to institutional and national data protection regulations.